The Physiological Role Of Glutathione-S-Transferase In The Intracellular Storage And Transport Of Nitric Oxide And Its Biomedical Effects
Funder
National Health and Medical Research Council
Funding Amount
$544,839.00
Summary
The aim of this project is to elucidate the mechanisms behind the intracellular regulation of nitrogen monoxide (NO) levels, which has broad implications for understanding NO activity in many processes which have major vital health implications, including the cytotoxic of macrophages and the control of blood pressure.
Prevention Of Drug Toxicities With Dichloroacetic Acid - The Implications For Cancer Chemotherapy
Funder
National Health and Medical Research Council
Funding Amount
$539,839.00
Summary
Many valuable cancer drugs have limited clinical use because of their toxic side effects. Our experiments with a new anti cancer drug called dichloroacetic acid (DCA) will determine if it can reduce the toxic effects of Cisplatin on the kidney and the effects of Doxorubicin on the heart.
Glutathione Transferase Zeta: A Novel Regulator Of Glucose And Lipid Metabolism
Funder
National Health and Medical Research Council
Funding Amount
$604,143.00
Summary
Obesity is a problem of global significance as a cause of preventable illness and death. The many consequences of obesity including cardiovascular disease, type 2 diabetes, cancer and osteoarthritis are an increasing burden on affected subjects and on the health care system. Our recent studies have revealed a novel pathway for the regulation of obesity. This discovery has provided a new target for the development of drugs for obesity and related disorders.
Investigating The Cellular Response To Iron-Depletion: The Trilogy Of ASK1, Thioredoxin And Ribonucleotide Reductase
Funder
National Health and Medical Research Council
Funding Amount
$552,572.00
Summary
Iron is crucial for many essential biological processes. Recently, we demonstrated that iron-depletion can affects important signalling pathways (e.g., JNK and p38) that play important roles in growth arrest and apoptosis. This study is designed to investigate the cellular and molecular effects of iron depletion which currently remains unclear. The research is crucial for understanding: (1) the effects of iron deficiency and (2) for understanding the effects of iron chelators that are used for t ....Iron is crucial for many essential biological processes. Recently, we demonstrated that iron-depletion can affects important signalling pathways (e.g., JNK and p38) that play important roles in growth arrest and apoptosis. This study is designed to investigate the cellular and molecular effects of iron depletion which currently remains unclear. The research is crucial for understanding: (1) the effects of iron deficiency and (2) for understanding the effects of iron chelators that are used for treating various diseases.Read moreRead less
Glutathione Transferase Omega 1 As A Novel Target For Sepsis And Other Inflammatory Disorders.
Funder
National Health and Medical Research Council
Funding Amount
$694,471.00
Summary
Sepsis is a major clinical problem that causes more deaths in Australia than breast, prostate or colon cancer. The deaths result from an overwhelming systemic inflammatory response to infection. We have discovered that this response is dependent on an enzyme called GSTO1-1 and that inhibitors can block the inflammatory response . In this study we will identify new drug like compounds that can inhibit GSTO1-1 and prevent death from sepsis.
New Cardiac Ryanodine Receptor Inhibitors For The Treatment Of Heart Failure
Funder
National Health and Medical Research Council
Funding Amount
$612,885.00
Summary
We have discovered that a protein that is recognized for its role in phase II detoxification can also modify the calcium signaling that underlies heart function. The small part of the protein that is active in heart tissue differs from the enzyme center that supports detoxification and can thus be used as a therapeutic agent in heart failure and in genetic cardiac conditions. The project is to develop the cardio-active part of the protein for maximum efficacy and for eventual clinical use.